益气补肾口服液配合化疗抗胃癌术后转移28例临床观察

刘云霞; 蒋沈君; 匡唐洪; 姚勇伟; 杨洁文; 王翌庆

doi:10.13288/j.11-2166/r.2008.02.050

您当前的位置：

首页 >

文章列表页 >

益气补肾口服液配合化疗抗胃癌术后转移28例临床观察

临床研究 | 更新时间：2021-11-17

- 益气补肾口服液配合化疗抗胃癌术后转移28例临床观察
- Clinical Observation on 28 Cases of the Metabasis of Stomach Cancer after Operation Treated by Yiqi Bushen Oral Liquid and Chemotherapy
- 中医杂志 2008年第2期页码：128-130
- 作者机构：
  
  1. 杭州市第三人民医院肿瘤科
  2. 杭州市第三人民医院肿瘤科浙江省杭州市西湖大道38号
  3. ,310009
- 作者简介：
- 基金信息：
  
  杭州市卫生局青年基金项目（青0204）
- DOI：10.13288/j.11-2166/r.2008.02.050
  中图分类号： R735.2
- 纸质出版：2008
- 稿件说明：
移动端阅览
[1]刘云霞,蒋沈君,匡唐洪,姚勇伟,杨洁文,王翌庆.益气补肾口服液配合化疗抗胃癌术后转移28例临床观察[J].中医杂志,2008(02):128-130.

LIU Yun-xia, JIANG Shen-jun, KUANG Tang-hong, et al. Clinical Observation on 28 Cases of the Metabasis of Stomach Cancer after Operation Treated by Yiqi Bushen Oral Liquid and Chemotherapy[J]. Journal of Traditional Chinese Medicine2008, (2): 128-130.
[1]刘云霞,蒋沈君,匡唐洪,姚勇伟,杨洁文,王翌庆.益气补肾口服液配合化疗抗胃癌术后转移28例临床观察[J].中医杂志,2008(02):128-130. DOI： 10.13288/j.11-2166/r.2008.02.050.

LIU Yun-xia, JIANG Shen-jun, KUANG Tang-hong, et al. Clinical Observation on 28 Cases of the Metabasis of Stomach Cancer after Operation Treated by Yiqi Bushen Oral Liquid and Chemotherapy[J]. Journal of Traditional Chinese Medicine2008, (2): 128-130. DOI： 10.13288/j.11-2166/r.2008.02.050.

摘要

目的观察益气补肾口服液配合化疗抗胃癌术后癌细胞转移的作用。方法胃癌术后脾肾亏虚证患者47例随机分为治疗组28例

对照组19例。对照组单纯接受化疗

治疗组在此基础上加服益气补肾口服液。12个月后观察两组患者局部复发及远处转移情况及其对生活质量、外周血象、免疫功能的影响。结果治疗组的术后复发转移率明显低于对照组（P<0.05）

Karnofsky评分、外周血象和免疫功能均较对照组有明显改善（P<0.01或P<0.05）。结论益气补肾口服液配合化疗具有较好的抗胃癌术后转移及增敏减毒作用

并且能改善患者的生活质量

提高免疫功能。

Abstract

Objective To study the effect of Yiqi Bushen （Reinforce qi and strengthen kidney） Oral Liquid and chemotherapy on the metabasis of stomach cancer after operation. Methods The 47 patients of stomach cancer after operation with the spleen and kidney deficiency syndrome were randomized into treatment group （n=28） and control group （n=19）. The control group was treated simply by chemotherapy and the treatment group by chemotherapy and Yiqi Bushen Oral Liquid. Condition of relapse and metabsis

quality of life

peripheral blood examination and immune function were observed 12 months later. Results The relapse and metabasis rate of treatment group was remarkably lower than that of control group （P<0.05）

the Karnofsky score

peripheral blood and immune function were all remarkably improved in comparison with control group （P<0.01 or P<0.05）. Conclusion Yiqi Bushen Oral Liquid together with chemotherapy has a good function in resisting the metabasis of stomach cancer after operation and increasing the sensitivity and decreasing the untoward reactions

and improving quality of life and immune function of patients as well.

关键词

Keywords

references

查看原文

浏览量

193

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

健脾养胃方加减对胃癌化疗患者肠道菌群的影响

六君子汤加减辅助化疗治疗晚期非小细胞肺癌31例临床观察

益气生血方对乳腺癌患者辅助化疗后骨髓抑制的影响

热敏灸对气虚痰瘀型非小细胞肺癌化疗患者生活质量及免疫功能影响的随机对照试验

基于“阴气在下，诸阳气浮”的化疗所致恶心呕吐辨治思路